SpaceX could remain under pressure as more insiders gain permission to sell. Here are the key dates

SpaceX is more than 28% off its recent peak and briefly fell below its $150 IPO price, with shares last around $161 after a blockbuster June 12 debut. The stock faces continued supply pressure as lockup expirations roll out over the next several months, including key unlocks around Aug. 10, Sept. 10, Sept. 25, Oct. 10, Oct. 25, early November, and Dec. 9. 22V Research warned that insider selling and unlock-related overhang could create better entry points, while also highlighting a Sept. 18 call-sale strategy at the $200 strike.

Analysis

The key setup here is not the headline volatility; it is the discontinuous supply profile. A post-IPO name with very limited float is being priced like a high-beta momentum asset, but the unlock schedule effectively turns the stock into a series of dated supply shocks, which usually compresses implied upside and steepens the left tail ahead of each event. That makes the stock less attractive as a directional long and more attractive as a volatility monetization vehicle until the market has digested the first few unlocks.

The second-order effect is that the pain may not be limited to the issuer. If the stock remains weak into each unlock window, late-stage private-market comps across high-profile consumer/tech growth names could face multiple compression, especially for companies still under the “pre-IPO scarcity premium” framing. That matters for funds and insiders who own baskets of late-stage privates, since a visible failure of post-IPO support tends to reduce appetite for adjacent deals and can tighten forward valuation marks.

Consensus is probably underestimating how mechanical the sell pressure can be once insider eligibility windows open. The near-term bid may look attractive after sharp drawdowns, but when supply arrives in discrete blocks, mean reversion often fails until after the event passes. The better trade is to sell convexity into the calendar rather than try to catch the knife; if the stock stabilizes, upside is likely capped by event risk, while if it breaks lower the path can remain disorderly for weeks, not days.

Key Decisions for Investors

• Sell upside convexity into the next unlock window: initiate a call overwrite against existing long exposure or buy-write structure on SPCX with expirations spanning the next listed unlock date; target collecting elevated premium while capping participation in a likely event-driven squeeze.
• For tactical traders, fade strength into the 1-2 weeks before each scheduled release rather than shorting into panic lows; use tight risk controls because post-unlock rallies can be sharp, but expect the better risk/reward to remain on pre-event weakness.
• If expressible in a liquid proxy, short a basket of high-beta late-stage IPO comps vs. quality mega-cap growth as a relative-value hedge; the thesis is that repeated supply shocks will pressure the entire scarcity-premium complex, not just this name.
• Avoid adding outright long exposure until after at least one unlock has cleared and volume normalizes; the expected payoff to waiting is improved entry by several percentage points with materially lower gap risk.
• For options accounts, consider a calendar/diagonal structure that benefits from elevated near-dated implied volatility around unlock dates while keeping limited directional exposure; this is preferable to naked long calls given the asymmetric downside into supply events.